Document: PRAC recommendations on signals adopted at the 10-13 February 2025 meeting-2025/3/17

Page: Variations requiring assessment (veterinary medicines)-2025/4/16

Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 5-8 May 2025 PRAC-2025/6/2

Document: Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products to address anti-D immunoglobulin supply chain vulnerabilities-2025/7/4

Document: Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate <210 mg / 300 mg / 405 mg> powder and solvent for prolonged release suspension for injection)-2024/8/7

Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2025/9/24

Page: CHMP opinions on consultation procedures-2025/11/3

Document: CAT quarterly highlights and approved ATMPs - December 2025-2025/12/2

Document: List of signals discussed at PRAC since September 2012-2026/1/6

Document: List of eligible industry stakeholder organisations-2026/2/10